Greenbury, Sam F.
Ougham, Kayleigh
Wu, Jinyi
Battersby, Cheryl
Gale, Chris
Modi, Neena
Angelini, Elsa D.
Funding for this research was provided by:
NIHR Imperial Biomedical Research Centre (Push for Impact)
Westminster Medical School Research Trust and the CW Chelsea and Westminster Hospital NHS Foundation Trust charity
Article History
Received: 1 June 2020
Accepted: 2 March 2021
First Online: 30 March 2021
Competing interests
: SG, KO, JW, CB and EA declare no competing interests. CG reports grants from Medical Research Council and the National Institute for Health Research during the conduct of the study; grants from National Institute for Health Research, Mason Medical Research Foundation, Rosetrees Foundation and from Canadian Institute for Health Research outside the submitted work. He reports grants and personal fees from Chiesi Pharmaceuticals outside of the submitted work; the grant is for a research study and the personal fee was to support attendance at an educational meeting. He is an unremunerated member of the Neonatal Data Analysis Unit (NDAU) Board which oversees the National Neonatal Research Database (NNRD). NM leads, directs and is Chief Investigator for the National Neonatal Research Database, and lead of the Neonatal Data Analysis Unit. NM is a member of the Board of Trustees of the David Harvey Trust, Medical Women’s Federation, Action Cerebral Palsy and TheirWorld, and the Nestle Scientific Advisory Board; she receives no personal remuneration for these roles. In the last five years NM has received research grants from the British Heart Foundation, Medical Research Council, National Institute of Health Research, Westminster Research Fund, Collaboration for Leadership in Applied Health and Care Northwest London, Healthcare Quality Improvement Partnership, Bliss, Prolacta Life Sciences, Chiesi, Shire and HCA International, and the European Health Data Evidence Network; travel and accommodation expenses from Prolacta, Nestle and Chiesi, and a lecture honorarium from Chiesi.